+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of surfactant treatment in late preterm infants with respiratory distress syndrome



Effects of surfactant treatment in late preterm infants with respiratory distress syndrome



Journal of Maternal-Fetal and Neonatal Medicine 31(10): 1259-1266



To evaluate surfactant effectiveness for the treatment of respiratory distress syndrome (RDS) in late preterm infants. We performed a retrospective cohort study of infants born between 34+0 and 36+6  weeks of gestation admitted for respiratory failure in seven perinatal centers from January 2010 to December 2014. We evaluated changes of FiO2, PaO2 and a/APO2 in surfactant-treated patients, and the need and duration of MV, the duration of noninvasive respiratory support, stay in NICU and in hospital in surfactant-treated and untreated late preterm infants with RDS alone. We studied 562 infants with RDS, 252 (45%) were treated with surfactant and 310 (55%) were not. FiO2, PaO2 and a/APO2 significantly improved after surfactant treatment. The adjusted odds ratio for the need of MV and the adjusted differences of duration of noninvasive respiratory support, and of NICU and hospital stay were not different in the surfactant and non-surfactant groups. Surfactant therapy was followed by a quick and persisting significant improvement of respiratory function in late preterm infants with RDS. Surfactant did not improve short-term outcomes in our population probably because other factors such as the gestational age, occurrence of complications and poor feeding play a relevant role.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059664508

Download citation: RISBibTeXText

PMID: 28367650

DOI: 10.1080/14767058.2017.1313828


Related references

A multicenter study on the surfactant treatment in late-preterm or term infants with respiratory distress syndrome. Zhonghua Er Ke Za Zhi 52(10): 724-728, 2014

Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment. Italian Journal of Pediatrics 40: 40, 2014

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond. Turkish Journal of Pediatrics 54(3): 239-246, 2012

The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome. Pathology, Research and Practice 205(1): 35-41, 2009

Modified bovine surfactant versus a protein-free surfactant in the treatment of respiratory distress syndrome in preterm infants A pilot study. Journal of the National Medical Association 86(1): 46-52, 1994

Microvascular permeability of the lung following surfactant treatment in preterm infants with Respiratory Distress Syndrome. Biology of the Neonate 69(3): 221, 1996

Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome. Journal of Huazhong University of Science and Technology. Medical Sciences 36(6): 801-805, 2016

Early use of calf pulmonary surfactant in late preterm and full-term infants with respiratory distress syndrome: a randomized controlled trial. Zhongguo Dang Dai Er Ke Za Zhi 16(3): 285-289, 2014

Surfactant Treatment Threshold during NCPAP for the Treatment of Preterm Infants with Respiratory Distress Syndrome. American Journal of Perinatology 33(10): 925-929, 2018

Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome. Pediatric Pulmonology 15(3): 157-162, 1993

Early prophylactic versus late selective use of surfactant for respiratory distress syndrome in very preterm infants: a collaborative study of 53 multi-center trials in Korea. Journal of Korean Medical Science 29(8): 1126-1131, 2014

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome. Health Science Reports 1(4): E34, 2018

Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial. Pediatric Pulmonology 14(1): 4-9, 1992

Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: Lisa vs Insure. Early Human Development 135: 32-36, 2019

Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome. Journal of Perinatal Medicine 37(5): 561-564, 2009